CLINICAL EFFICIENCY OF ZINC PYRITHIONE TO TREAT ATOPIC DERMATITIS IN CHILDREN

Atopic dermatitis is one of the most widespread children's diseases, it has a chronic recurrent clinical course, may be often complicated with the secondary infection. This necessitates the choice of a medication to impact all stages of the disease process with a high safety profile. This diges...

Full description

Saved in:
Bibliographic Details
Main Authors: D.S. Korostovtsev (Author), A.N. Pampura (Author), R.S. Fassakhov (Author), E.O. Sukmanskaya (Author), F.I. Petrovsky (Author)
Format: Book
Published: Union of pediatricians of Russia, 2009-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a9a9345d64f43d9a059b31c3698b2bc
042 |a dc 
100 1 0 |a D.S. Korostovtsev  |e author 
700 1 0 |a A.N. Pampura  |e author 
700 1 0 |a R.S. Fassakhov  |e author 
700 1 0 |a E.O. Sukmanskaya  |e author 
700 1 0 |a F.I. Petrovsky  |e author 
245 0 0 |a CLINICAL EFFICIENCY OF ZINC PYRITHIONE TO TREAT ATOPIC DERMATITIS IN CHILDREN 
260 |b Union of pediatricians of Russia,   |c 2009-02-01T00:00:00Z. 
500 |a 1727-5776 
500 |a 2500-3089 
520 |a Atopic dermatitis is one of the most widespread children's diseases, it has a chronic recurrent clinical course, may be often complicated with the secondary infection. This necessitates the choice of a medication to impact all stages of the disease process with a high safety profile. This digest is devoted to activated zinc pyrithione. Overall, currently available data make it possible to state that this agent is one of the most effective and safest products to be used for a local therapy of atopic dermatitis in children. Key words: atopic dermatitis, activated zinc pyrithione, children 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Педиатрическая фармакология, Vol 6, Iss 1, Pp 64-69 (2009) 
787 0 |n https://www.pedpharma.ru/jour/article/view/1047 
787 0 |n https://doaj.org/toc/1727-5776 
787 0 |n https://doaj.org/toc/2500-3089 
856 4 1 |u https://doaj.org/article/9a9a9345d64f43d9a059b31c3698b2bc  |z Connect to this object online.